Xcout IntelOneSkin
OneSkin, Inc. is a for-profit biotechnology and cosmetics company operating in the beauty, health care, and personal care sectors. Recognized on Fast Company's Most Innovative Companies List in 2024, the company is headquartered in San Francisco, California.
Subscribe to see OneSkin’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
OneSkin at a glance
OneSkin is a biotech company headquartered in United States. It has raised at least $52.9M across the 5 funding rounds on record. Its most recent funding round raised $20.4M in May 2025. Xcout tracks 3 named people at OneSkin, including Carolina Reis de Oliveira (President). Xcout recorded 2 job postings from OneSkin in the last 90 days, naming tools such as NetSuite.
OneSkin leadership
- Carolina Reis de OliveiraPresident
- Alessandra ZonariDirector
- Tara PoseleyDirector
OneSkin funding rounds
At least $52.9M raised across the 5 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $20.4M | — | |
| SEC Form D filing | $7M | — | |
| SEC Form D filing | $12.4M | — | |
| SEC Form D filing | $626,594 | — | |
| Series A | $12.5M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Hiring at OneSkin
Xcout recorded 2 job postings from OneSkin in the last 90 days, from a hiring record Xcout has kept since July 2026.
Tools named in OneSkin's job postings
The weekly hiring trend, the roles and locations behind it — see OneSkin's hiring signals →
OneSkin competitors
A few of OneSkin's closest competitors — see the full list of competitors and alternatives →
Outer Biosciences specializes in developing breakthrough bioactives for skin health by discovering novel components from underexplored natural sources using an advanced ex vivo platform. Headquartered in Malden, the company aims to improve human health and skin care through innovative biological research.
One Biosciences is a biotechnology company headquartered in Paris, France. It is driven by innovative scientists and biotech leaders focused on advancing precision medicine and novel therapies for patients.
Ankasa Regenerative Therapeutics, Inc. is a for-profit biotechnology company headquartered in South San Francisco, California.
Geltor is an Emeryville, California-based biotechnology research company powered by its Biodesigner AI™ platform to create sustainable, animal-free specialty proteins for beauty, personal care, and nutrition markets.
Dermata Therapeutics, Inc. operates as a clinical-stage biotechnology enterprise, concentrating its efforts on discovering, advancing, and bringing to market novel pharmaceutical treatments designed to address various medical and cosmetic skin ailments. The company's principal experimental drug, DMT310, has successfully finished Phase IIb clinical trials for moderate-to-severe acne and completed a Phase Ib proof-of-concept study for mild-to-moderate psoriasis. Furthermore, DMT310 is presently undergoing Phase 2 clinical evaluation for moderate-to-severe rosacea. Dermata is also progressing with DMT410, which has concluded Phase Ib proof-of-concept trials aimed at managing hyperhidrosis and other aesthetic concerns. Established in 2014, the firm maintains its headquarters in San Diego, California.
Checkerspot, Inc. is a for-profit active company specializing in innovation through biotechnology, such as healthy fats and oils from fermentation and bio-based cosmetic ingredients.
Get OneSkin's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on OneSkin in Xcout Intel
- 3 named people with titles, LinkedIn and board committees
- 5 funding rounds with the investors in each, and who they co-invest with
- Weekly hiring history and the mix of roles behind it
- The full competitor set, tracking, exports and API access